Close Menu

NEW YORK – Meridian Bioscience reported on Friday that its fiscal first quarter revenues decreased 8 percent year over year partially due to lower contract pricing for certain gastrointestinal products.

For the three months ended Dec. 31, 2019 the firm reported revenues of $47.4 million, down from $51.5 million a year ago. Meridian missed the average Wall Street estimate of $48.7 million.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The World Health Organization will be providing low-cost COVID-19 tests to low- and middle-income nations, according to Reuters.

Nature News examines how the confirmation of Amy Coney Barrett to the US Supreme Court could affect scientific agencies.

Nobel Prize-winner Arthur Ashkin, who developed optical tweezers, has died at 98, the Washington Post reports.

In PNAS this week: altered gene expression in brain samples from Alzheimer's disease patients, effects of gene mutations found in bladder cancer, and more.